Arul Mahadevan

4.2k total citations · 1 hit paper
22 papers, 3.2k citations indexed

About

Arul Mahadevan is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arul Mahadevan has authored 22 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 12 papers in Radiation and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arul Mahadevan's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (14 papers) and Advanced Radiotherapy Techniques (12 papers). Arul Mahadevan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (14 papers) and Advanced Radiotherapy Techniques (12 papers). Arul Mahadevan collaborates with scholars based in United States, Czechia and Israel. Arul Mahadevan's co-authors include Eric A. Klein, Patrick A. Kupelian, C.A. Reddy, Jay P. Ciezki, Twyla R. Willoughby, Howard M. Sandler, Martin G. Sanda, Irving Kaplan, Deborah A. Kuban and John T. Wei and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Arul Mahadevan

22 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

2008 1.7k citations Martin G. Sanda, Rodney L. Dunn et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Arul Mahadevan

Since Specialization

Citations

This map shows the geographic impact of Arul Mahadevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arul Mahadevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arul Mahadevan more than expected).

Fields of papers citing papers by Arul Mahadevan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arul Mahadevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arul Mahadevan. The network helps show where Arul Mahadevan may publish in the future.

Co-authorship network of co-authors of Arul Mahadevan

This figure shows the co-authorship network connecting the top 25 collaborators of Arul Mahadevan. A scholar is included among the top collaborators of Arul Mahadevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arul Mahadevan. Arul Mahadevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Causes of Mortality After Dose-Escalated Radiation Therapy and Androgen Deprivation for High-Risk Prostate Cancer 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Rahul D. Tendulkar, G.K. Hunter, C.A. Reddy, Kevin L. Stephans, Jay P. Ciezki, May Abdel–Wahab, Andrew J. Stephenson, Eric A. Klein, Arul Mahadevan, Patrick A. Kupelian	15
2	Redefining High-Risk Prostate Cancer Based on Distant Metastases and Mortality After High-Dose Radiotherapy With Androgen Deprivation Therapy 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Rahul D. Tendulkar, C.A. Reddy, Kevin L. Stephans, Jay P. Ciezki, Eric A. Klein, Arul Mahadevan, Patrick A. Kupelian	21
3	Prostate Intrafraction Translation Margins for Real-Time Monitoring and Correction Strategies 2011 ·SHILAP Revista de lepidopterología ·Dale W. Litzenberg, James M. Balter, Scott Hadley, Daniel A. Hamstra, Twyla R. Willoughby, Patrick A. Kupelian, T. Djemil, Arul Mahadevan, Shirish Jani, G. Weinstein, Timothy D. Solberg, Charles A. Enke, L. Levine, Howard M. Sandler	21
4	INITIAL USE OF BODY-GPS FOR 4-D AUGMENTED REALITY SURGICAL NAVIGATION SYSTEM 2009 ·The Journal of Urology ·Osamu Ukimura, Tsuneharu Miki, Arul Mahadevan, Masahiko Nakamoto, Yoshinobu Sato, Makoto Hashizume, Mihir Desai, (unknown), Monish Aron, Brian R. Herts, Inderbir S. Gill	4
5	Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors breakdown → 2008 ·New England Journal of Medicine ·Martin G. Sanda, Rodney L. Dunn, Jeff M. Michalski, Howard M. Sandler, Laurel Northouse, Larry Hembroff, Xihong Lin, Thomas K. Greenfield, Mark S. Litwin, Christopher S. Saigal, Arul Mahadevan, Eric A. Klein, Adam S. Kibel, Louis L. Pisters, Deborah A. Kuban, Irving Kaplan, David P. Wood, Jay P. Ciezki, Nikhil Shah, John T. Wei	1691
6	Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy? 2008 ·Urologic Oncology Seminars and Original Investigations ·Eric A. Klein, Jay P. Ciezki, Patrick A. Kupelian, Arul Mahadevan	48
7	Prediction of Intrafraction Prostate Motion: Accuracy of Pre- and Post-Treatment Imaging and Intermittent Imaging 2008 ·International Journal of Radiation OncologyBiologyPhysics ·C. Noël, Parag J. Parikh, (unknown), Patrick A. Kupelian, Arul Mahadevan, G. Weinstein, Charles A. Enke, N. Flores, David Beyer, L. Levine	55
8	Comparison of Biochemical Relapse-Free Survival Between Primary Gleason Score 3 and Primary Gleason Score 4 for Biopsy Gleason Score 7 Prostate Cancer 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Michael J. Burdick, C.A. Reddy, James Ulchaker, Kenneth W. Angermeier, Andrew Altman, Nabil El Hage Chehade, Arul Mahadevan, Patrick A. Kupelian, Eric A. Klein, Jay P. Ciezki	51
9	Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Twyla R. Willoughby, C.A. Reddy, Eric A. Klein, Arul Mahadevan	291
10	Effect of Increasing Radiation Doses on Local and Distant Failures in Patients With Localized Prostate Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Jay P. Ciezki, C.A. Reddy, Eric A. Klein, Arul Mahadevan	55
11	Impact of Image Guidance on Outcomes After External Beam Radiotherapy for Localized Prostate Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Twyla R. Willoughby, C.A. Reddy, Eric A. Klein, Arul Mahadevan	58
12	Renal Radiosurgery: Initial Clinical Experience With Histological Evaluation 2007 ·Surgical Innovation ·Lee Ponsky, Arul Mahadevan, (unknown), T. Djemil, Andrew C. Novick	28
13	Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer 2006 ·Urology ·Patrick A. Kupelian, Arul Mahadevan, C.A. Reddy, Alwyn M. Reuther, Eric A. Klein	101
14	Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Twyla R. Willoughby, Arul Mahadevan, T. Djemil, G. Weinstein, Shirish Jani, Charles A. Enke, Timothy D. Solberg, N. Flores, David Liu, David Beyer, L. Levine	402
15	Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostate 2006 ·Urology ·(unknown), Jay P. Ciezki, C.A. Reddy, Kenneth W. Angermeier, James Ulchaker, Arul Mahadevan, Nabil El Hage Chehade, Andrew Altman, (unknown), Eric A. Klein	12
16	Aggressiveness of Familial Prostate Cancer 2006 ·Journal of Clinical Oncology ·Patrick A. Kupelian, C.A. Reddy, Alwyn M. Reuther, Arul Mahadevan, Jay P. Ciezki, Eric A. Klein	26
17	Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, (unknown), Deepak Khuntia, C.A. Reddy, Eric A. Klein, Arul Mahadevan	158
18	PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Jay P. Ciezki, C.A. Reddy, Jorge García, Kenneth W. Angermeier, James Ulchaker, Arul Mahadevan, Nabil El Hage Chehade, Andrew Altman, Eric A. Klein	78
19	A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Jay P. Ciezki, Eric A. Klein, Kenneth W. Angermeier, James Ulchaker, Nabil El Hage Chehade, Andrew Altman, Arul Mahadevan, C.A. Reddy	38
20	Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era 2004 ·Cancer ·Deepak Khuntia, C.A. Reddy, Arul Mahadevan, Eric A. Klein, Patrick A. Kupelian	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact